BWFA
AGN.PRA

Baltimore-Washington Financial Advisors’s Allergan plc AGN.PRA Stock Holding History

Baltimore-Washington Financial Advisors’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,315
Closed -$5.36M – 75
2017
Q1 		$5.36M Buy
6,315
+100
+2% +$82.9K 1.36% 37
2016
Q4 		$4.74M Sell
6,215
-1,823
-23% -$1.38M 1.3% 40
2016
Q3 		$6.6M Buy
8,038
+145
+2% +$125K 1.88% 21
2016
Q2 		$6.58M Buy
7,893
+1,727
+28% +$1.44M 1.96% 18
2016
Q1 		$5.67M Buy
+6,166
New +$5.9M 1.72% 25

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

Baltimore-Washington Financial Advisors's AGN.PRA Position: Q2 2017 in Review

Baltimore-Washington Financial Advisors sold out of Allergan plc (AGN.PRA) in Q2 2017, closing a stake of 6,315 shares — an estimated $5.36M sold.

Baltimore-Washington Financial Advisors first reported a position in AGN.PRA in Q1 2016 and held it in 5 quarters. The position peaked at $6.6M in Q3 2016. 109 funds tracked by Wall St. Rank hold AGN.PRA as of Q2 2017.

  • Baltimore-Washington Financial Advisors reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Baltimore-Washington Financial Advisors sold 6,315 Allergan plc shares in Q2 2017, an estimated $5.36M.
  • Baltimore-Washington Financial Advisors first reported a position in Allergan plc in Q1 2016 and held it in 5 quarters.
  • Baltimore-Washington Financial Advisors's Allergan plc position peaked at $6.6M in Q3 2016.
  • 109 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q2 2017, filed 17 Jul 2017.